Patents by Inventor Shelley Miyamoto

Shelley Miyamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective inhibition of ?1-adrenergic receptors for the treatment of pediatric heart failure
    Patent number: 9456997
    Abstract: Provided are methods of treating heart failure in children using B1-selective adrenergic receptor antagonists, alone or in combination with other agents, including B-2-selective adrenergic receptor agonists.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: October 4, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: Brian Stauffer, Carmen Sucharov, Shelley Miyamoto
  • MIRNAS AS A PROGNOSTIC BIOMARKER IN PEDIATRIC HEART FAILURE
    Publication number: 20140274923
    Abstract: The present invention provides for methods of predicting progression of pediatric heart failure using miRNA biomarkers, as well as subsequent treatment of patients based on their classification.
    Type: Application
    Filed: March 10, 2014
    Publication date: September 18, 2014
    Inventors: Carmen Sucharov, Brian Stauffer, Shelley Miyamoto
  • SELECTIVE INHIBITION OF BETA1- ADRENERGIC RECEPTORS FOR THE TREATMENT OF PEDIATRIC HEART FAILURE
    Publication number: 20130296416
    Abstract: Provided are methods of treating heart failure in children using B1-selective adrenergic receptor antagonists, alone or in combination with other agents, including B-2-selective adrenergic receptor agonists.
    Type: Application
    Filed: August 25, 2011
    Publication date: November 7, 2013
    Applicant: The Regents of the University of Colorado, A Body Corporate
    Inventors: Brian Stauffer, Carmen Sucharov, Shelley Miyamoto